1. Home
  2. CLSD vs CRT Comparison

CLSD vs CRT Comparison

Compare CLSD & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • CRT
  • Stock Information
  • Founded
  • CLSD 2011
  • CRT 1991
  • Country
  • CLSD United States
  • CRT United States
  • Employees
  • CLSD N/A
  • CRT N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • CRT Oil & Gas Production
  • Sector
  • CLSD Health Care
  • CRT Energy
  • Exchange
  • CLSD Nasdaq
  • CRT Nasdaq
  • Market Cap
  • CLSD 59.1M
  • CRT 65.1M
  • IPO Year
  • CLSD 2016
  • CRT 1992
  • Fundamental
  • Price
  • CLSD $0.79
  • CRT $9.86
  • Analyst Decision
  • CLSD Strong Buy
  • CRT
  • Analyst Count
  • CLSD 5
  • CRT 0
  • Target Price
  • CLSD $4.80
  • CRT N/A
  • AVG Volume (30 Days)
  • CLSD 417.4K
  • CRT 22.1K
  • Earning Date
  • CLSD 08-11-2025
  • CRT 01-01-0001
  • Dividend Yield
  • CLSD N/A
  • CRT 8.96%
  • EPS Growth
  • CLSD N/A
  • CRT N/A
  • EPS
  • CLSD N/A
  • CRT 0.99
  • Revenue
  • CLSD $3,764,000.00
  • CRT $6,834,116.00
  • Revenue This Year
  • CLSD $60.52
  • CRT N/A
  • Revenue Next Year
  • CLSD $88.28
  • CRT N/A
  • P/E Ratio
  • CLSD N/A
  • CRT $9.94
  • Revenue Growth
  • CLSD N/A
  • CRT N/A
  • 52 Week Low
  • CLSD $0.70
  • CRT $8.88
  • 52 Week High
  • CLSD $1.65
  • CRT $13.31
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 46.69
  • CRT 47.00
  • Support Level
  • CLSD $0.77
  • CRT $9.74
  • Resistance Level
  • CLSD $0.82
  • CRT $9.88
  • Average True Range (ATR)
  • CLSD 0.04
  • CRT 0.18
  • MACD
  • CLSD 0.00
  • CRT 0.01
  • Stochastic Oscillator
  • CLSD 28.50
  • CRT 27.78

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: